More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

The new electric SUV from MG – spotted being evaluated for Australia last month ... He is a mechanical engineer who spent the first 7 years of his career building transport infrastructure before ...

In terms of size, the Cyberster is 4.54 meters long, 1.91 meters wide, and 1.3 meters high, with a wheelbase of 2.7 meters, making it larger than a Porsche 911 Turbo. The MG Cyberster is a stylish and ...

Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the year. Bengaluru: Novo Nordisk's announced on Monday that an oral version of ...

The MycarinG study subgroup analysis indicated greater numerical improvement in the 7 mg/kg dose group, possibly due to more severe baseline symptoms. Rozanolixizumab was well-tolerated ...

Credit: fcm82 / Shutterstock. On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist, Rybelsus, which is ...

Novo Nordisk will present more detailed data in 2025 and it intends to file for an expanded label for Rybelsus for this population. Oral semaglutide is administered once daily and is approved for use ...

Bernstein said Novo Nordisk’s (NVO) recently released SOUL study results for Rybelsus in the reduction of major cardiovascular events in diabetic patients were modest and not as robust as ...

Please note that NVO already markets oral semaglutide in the United States under the brand name Rybelsus. It is administered once daily and comes in three approved doses, 3 mg, 7 mg and 14 mg.